MaxCyte Inc

MXCT · NASDAQ

Research and Development in Biotechnology

MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization.

ESG Scores

Overall ESG

4.1

Environmental

6.3

Social

3.4

Governance

5.7

Public ESG Grades

Overall: BB (Medium)

E: BS: BBG: B

Gender Diversity

Female Directors0.11109999999999999%

CEO GenderMale

Market Data

Price$1.17-0.07 (-5.65%)

Market Cap$126M

P/E Ratio—

EPS$—

52W High$2.37

52W Low$0.64

Beta1.47